- Home
- ARL vs AMRN Comparison
ARL vs AMRN Comparison
Compare ARL & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARL
- AMRN
- Stock Information
- Founded
- ARL 1999
- AMRN 1989
- Country
- ARL United States
- AMRN Ireland
- Employees
- ARL N/A
- AMRN N/A
- Industry
- ARL Building operators
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- ARL Real Estate
- AMRN Health Care
- Exchange
- ARL Nasdaq
- AMRN Nasdaq
- Market Cap
- ARL 233.2M
- AMRN 216.0M
- IPO Year
- ARL N/A
- AMRN 1993
- Fundamental
- Price
- ARL $14.20
- AMRN $16.10
- Analyst Decision
- ARL
- AMRN Strong Sell
- Analyst Count
- ARL 0
- AMRN 1
- Target Price
- ARL N/A
- AMRN $12.00
- AVG Volume (30 Days)
- ARL 3.8K
- AMRN 173.6K
- Earning Date
- ARL 08-07-2025
- AMRN 07-30-2025
- Dividend Yield
- ARL N/A
- AMRN N/A
- EPS Growth
- ARL N/A
- AMRN N/A
- EPS
- ARL N/A
- AMRN N/A
- Revenue
- ARL $48,234,000.00
- AMRN $214,112,000.00
- Revenue This Year
- ARL N/A
- AMRN N/A
- Revenue Next Year
- ARL N/A
- AMRN N/A
- P/E Ratio
- ARL N/A
- AMRN N/A
- Revenue Growth
- ARL N/A
- AMRN N/A
- 52 Week Low
- ARL $9.43
- AMRN $7.08
- 52 Week High
- ARL $22.77
- AMRN $17.49
- Technical
- Relative Strength Index (RSI)
- ARL 57.31
- AMRN 60.25
- Support Level
- ARL $13.22
- AMRN $16.12
- Resistance Level
- ARL $15.00
- AMRN $17.49
- Average True Range (ATR)
- ARL 0.59
- AMRN 1.01
- MACD
- ARL 0.01
- AMRN -0.06
- Stochastic Oscillator
- ARL 77.51
- AMRN 62.73
About ARL American Realty Investors Inc.
American Realty Investors Inc is a fully integrated externally managed real estate company. The company operates high-quality multifamily and commercial properties throughout the Southern United States and also invests in mortgage notes receivable and in land that is either held for appreciation or development. It operates in two reportable segments; the acquisition, development, ownership and management of multifamily properties (Residential); and the acquisition, development, ownership, and management of commercial properties (Commercial), which predominantly comprise office properties. Maximum revenue is generated from its Residential segment, which includes the rental of apartments and other tenants.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.